• Galderma Announces Triple Approval of New State-of-the-art Restylane Syringe in the EU, the U.S. and Canada

    February 25, 2026

    Regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art Restylane syringe for use with its Restylane NASHA [...]

  • We Are All Sculptra: First-of-its-Kind Initiative from Galderma

    February 19, 2026

    Galderma, the pure-play dermatology category leader, unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra [...]

  • Q&A: Merz Aesthetics Celebrates 15 Years of Xeomin (incobotulinumtoxinA) with Campaign Refresh, Sweepstakes

    February 11, 2026

    By Madilyn Moeller, Marketing Content Coordinator, American Med Spa Association (AmSpa)Merz Aesthetics is celebrating 15 years since the U.S. Food and Drug [...]

  • NEW JERSEY Bill Creates Path to Independence for Advanced Practice Nurses

    February 5, 2026

    Bill Name: Senate Bill 2996 (S 2996)  Assembly Bill 4052 (A 4052)Primary Sponsor: S 2996 Senator Joseph Vitale, Senator Troy Singleton      [...]

  • Galderma’s RelabotulinumtoxinA Moves Closer to U.S. Market After FDA Accepts BLA Resubmission

    February 5, 2026

    Galderma announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application (BLA) for RelabotulinumtoxinA, a [...]

  • Medical Spa Show 2026 Headlined by Steven Dayan, MD, Erika Barry, NP-C, and Kay Durairaj, MD

    February 5, 2026

    Dr. Steven Dayan, keynote speaker at AmSpa's Medical Spa Show, April 9 - 12, 2026 at Wynn Las Vegas.Medical Spa Show 2026 [...]

  • Kairos Aesthetic Medicine Opens in Dallas–Fort Worth

    February 4, 2026

    Kairos Aesthetic Medicine, founded by Taylor Siemens, NP-C, has announced its opening in the Dallas–Fort Worth area. The new clinician-led aesthetic and [...]

  • Obagi Launches ALOHA Program with Clinical Contributions from VIO Med Spa, Alpha Aesthetic Partners

    February 3, 2026

    Obagi Medical has launched a large‑scale, practice‑driven clinical initiative designed to gather real‑world evidence on its first FDA‑approved hyaluronic acid filler, Obagi [...]

  • Exosomes, Plasma, and Profit: The Treatment Stack That’s Transforming Aesthetic Practices, Insights From Dr. Chris Croley

    January 16, 2026

    Win Free Exosomes → Simply Register for the Free Exosome Masterclass By MedResultsIn today’s rapidly evolving aesthetic landscape, one reality is becoming [...]

  • FDA Approves RHA Dynamic Volume for Cheek Augmentation, Midface Contouring

    January 15, 2026

    RHA Dynamic Volume filler can now be injected in the cheeks and midface.The U.S. Food and Drug Administration (FDA) has approved RHA [...]

  • UNC-Chapel Hill Joins Boston College, Columbia University in Offering Aesthetic Injectable Courses with LexRx

    January 7, 2026

    The University of North Carolina at Chapel Hill School of Nursing and Boston-based LexRX have partnered to offer introductory level aesthetic injectables [...]

  • FDA Clears First Oral GLP-1 for Weight Loss

    December 23, 2025

    On December 22, 2025, the FDA approved Novo Nordisk’s once-daily Wegovy pill (25 mg semaglutide), the first oral GLP-1 receptor agonist indicated for [...]